Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check5 days agoChange DetectedThe displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study history now includes a new revision v3.7.0 and removes the older v3.6.6 from the visible history, updating the record's version history.SummaryDifference0.1%

- Check47 days agoChange DetectedA newer site revision tag (v3.6.6) has been added to the page, signaling an underlying platform update for the Record History view. This change does not modify the study data or how the history is displayed.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision v3.6.5 is added to the record history to replace the prior v3.6.4, representing an update to the page's metadata.SummaryDifference0.1%

- Check83 days agoChange DetectedA new page revision, v3.6.4, was added to the record history, and the previous revision, v3.6.3, was removed. This update reflects a change to the page's build/version metadata within the history.SummaryDifference0.1%

- Check104 days agoChange DetectedThe record history now lists a new Revision: v3.6.3, replacing Revision: v3.6.2, indicating an update to the page’s release version shown in the history.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.